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Salmonella enterica serovar Typhimurium (S. Typhimurium) is a Gram-negative bacte-
rium that produces disease in numerous hosts. In mice, oral inoculation is followed by 
intestinal colonization and subsequent systemic dissemination, which leads to severe 
pathogenesis without the activation of an efficient anti-Salmonella immune response. 
This feature suggests that the infection caused by S. Typhimurium may promote the 
production of anti-inflammatory molecules by the host that prevent efficient T cell acti-
vation and bacterial clearance. In this study, we describe the contribution of immune 
cells producing the anti-inflammatory cytokine interleukin-10 (IL-10) to the systemic 
infection caused by S. Typhimurium in mice. We observed that the production of IL-10 
was required by S. Typhimurium to cause a systemic disease, since mice lacking 
IL-10 (IL-10−/−) were significantly more resistant to die after an infection as compared 
to wild-type (WT) mice. IL-10−/− mice had reduced bacterial loads in internal organs 
and increased levels of pro-inflammatory cytokines in serum at 5 days of infection. 
Importantly, WT mice showed high bacterial loads in tissues and no increase of cyto-
kines in serum after 5 days of S. Typhimurium infection, except for IL-10. In WT mice, 
we observed a peak of il-10 messenger RNA production in ileum, spleen, and liver 
after 5 days of infection. Importantly, the adoptive transfer of T or B cells from WT mice 
restored the susceptibility of IL-10−/− mice to systemic S. Typhimurium infection, sug-
gesting that the generation of regulatory cells in vivo is required to sustain a systemic 
infection by S. Typhimurium. These findings support the notion that IL-10 production 
Abbreviations: S. Typhimurium, Salmonella enterica serovar Typhimurium; IL-10, interleukin-10; DCs, dendritic cells; 
BMM, bone marrow-derived macrophages; EGFP, enhanced green fluorescent protein; MOI, multiplicity of infection; Treg, 
regulatory T cells.
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from lymphoid cells is a key process in the infective cycle of S. Typhimurium in mice 
due to generation of a tolerogenic immune response that prevents bacterial clearance 
and supports systemic dissemination.
Keywords: Salmonella enterica serovar Typhimurium, interleukin-10, T cells, B cells, dendritic cells, macrophages, 
systemic infection, regulatory T cells
inTrODUcTiOn
The infection caused by Salmonella enterica has a great impact in 
public health, both in industrialized and developing countries, 
because it is one of the most common causes of food-borne ill-
ness and a major cause of acute gastrointestinal ailment (1–3). 
Furthermore, some Salmonella serovars, such as S. enterica 
serovar Typhi (S. Typhi), are highly virulent for humans. 
S. Typhi is a host-restricted serovar that causes typhoid fever in 
humans due to oral ingestion of the bacteria through contami-
nated food or water. The disease caused by S. Typhi in humans 
is not related initially to gastrointestinal symptoms, but it is 
characterized by fever, bacteremia, and hepato-splenomegaly. 
In the absence of appropriate treatment, it can lead to intestinal 
hemorrhage or perforation (4, 5). Importantly, some patients 
become asymptomatic carriers and harbor the bacteria in 
gallbladder (6–8). One hallmark of S. Typhi infection is its 
ability to prevent the immune response activation to sterilize 
infected tissues. Thus, understanding the interaction of this 
bacterium with the host immune response is relevant to design 
more efficacious vaccines and immunotherapies to prevent this 
life-threatening disease.
Recently, a study performed in healthy volunteers highlighted 
the role of regulatory T  cells (Treg cells) in the outcome of 
S. Typhi infection. This study showed that a single oral infection 
with this bacterium increases the amount of circulating Treg 
cells in peripheral blood (9). Interestingly, among the volunteers 
included in the study, those who developed typhoid disease 
symptoms expressed higher levels α4β7 integrin in Treg cells 
pre-challenge (9). This specific integrin is gut-homing molecule, 
probably accounts for the location of Treg cells in the intestine 
upon S. Typhi infection. Because one of the main molecules 
involved in the generation of Treg cells is interleukin-10 (IL-
10), it is possible that this cytokine is involved in the ability of 
S. enterica to avoid the immune response activation. IL-10 is an 
anti-inflammatory cytokine, the general effects of which seems 
to be oriented at reducing inflammatory immune responses and 
prevents tissue damage (10, 11). IL-10 is secreted by cells of the 
innate and adaptive immune system, such as macrophages, DCs, 
myeloid-derived suppressor cells, neutrophils, B cells, and T cells 
(12). It has been suggested that by acting on antigen-presenting 
cells, i.e., macrophages and DCs, IL-10 can inhibit the develop-
ment of Th1 type immune responses, reduce NK cell responses, 
prevent the differentiation of naïve T cells into effector cytotoxic 
T cells, and dampen the secretion of pro-inflammatory cytokines, 
such as IL-12 (13). Furthermore, IL-10 induces Treg cell prolif-
eration, promoting an equilibrated immune response that control 
pathogen infection, altogether reducing excessive inflammatory 
damage to the affected tissues (14, 15).
Infection caused by S. Typhimurium in mice resembles the 
disease caused by S. Typhi in humans and, thus, this murine 
model provides a valuable tool for evaluating the infectious cycle 
and the immune response related to systemic Salmonella infec-
tion. C57BL/6 are highly susceptible to S. Typhimurium infec-
tion, causing 100% mortality after 10–14 days of an oral infect ion. 
Furthermore, in these animals, no specific T cell acti vation can 
be detected after infection (16–20). Therefore, S. Typhimurium 
might promote the activation of anti-inflammatory or tolero-
genic mechanisms in these mice to favor systemic infection 
without immune response activation. Previous studies have 
shown that the innate IL-10 production by B  cells is required 
by S. Typhimurium to cause systemic infections in mice, since 
transfer of B cells from mice unable to produce IL-10 increases 
their resistance to the infection (21). This study also suggested 
that B cell stimulation by Salmonella LPS, via TLR4 is a major 
stimulus for IL-10 production by these cells to promote systemic 
infection (21). Other studies have described that co-infection 
of S. Typhimurium with Plasmodium falciparum enhances the 
capacity of the bacteria to produce a systemic infection due to the 
increased production of IL-10 by the host, induced by this parasite 
(22, 23). In agreement with the role of IL-10 in S. Typhimurium 
infection, a reduced capacity of S. Typhimurium to cause 
systemic infection was described in mice treated with a neutral-
izing antibody that blocks the function of IL-10 (24). Interestin-
gly, studies assessing persistent pathogens, such as Leishmania 
major (25), human cytomegalovirus (26), or Mycobacterium 
tuberculosis (27), have demonstrated that the absence of IL-10 
leads to a better clearance of these pathogens, with variable 
degrees of immunopathology.
In this study, we demonstrate that the active induction of 
IL-10 production by both, B and T cells during S. Typhimurium 
infection is fundamental to generate a systemic infection in 
C57BL/6 mice. Our results support the notion that S. Typh-
imurium infection promotes the generation of a tolerogenic 
immune response characterized by an increased production of 
IL-10 in the intestine, spleen, and liver, preventing clearance of 
the bacteria from infected tissues.
MaTerials anD MeThODs
ethics statement
All the experiments using mice were conducted in agreement 
with the ethical standards and according to the local animal 
protection law. All experimental protocols were reviewed and 
approved by the Scientific Ethical Committee for Animal and 
Environment Care of the Pontificia Universidad Católica de 
Chile (Protocol number CBB-208/2013).
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Bacterial strains and culture conditions
S. Typhimurium ATCC14028 strain was originally obtained 
from American Type Culture Collection and kindly provided by 
Dr. Carlos Santiviago (Universidad de Chile, Santiago, Chile). 
S. Typhimurium aliquots were stored at −80°C in Luria-Bertani 
(LB) broth (tryptone 1%, yeast extract 0.5%, and NaCl 0.5%) 
supplemented with 20% glycerol. To perform the infection 
assays, aliquots were thawed and then grown with agitation at 
37°C in LB broth until OD600 equal to 0.6. Then, bacterial doses 
were resuspended in sterile phosphate-buffered saline (PBS). 
All experimental protocols that included biohazards were 
reviewed and approved by the Scientific Ethical Committee for 
Research Safety of the Pontificia Universidad Católica de Chile 
(Protocol number CBB-208/2013).
Mice strains and infection Protocol
Six- to eight-week-old C57BL/6 wild-type mice (WT), C57BL/6 
IL-10−/− mice (IL-10−/−), C57BL/6 IL-10/GFP reporter mice 
(Vert-X), and C57BL/6 Rag.1−/− mice were originally purchased 
from Jackson Laboratories (Bar Harbor, ME, USA) and main-
tained in the pathogen-free animal facility at the Facultad de 
Ciencias Biológicas, Pontificia Universidad Católica de Chile. 
For intragastric infection (i.g), mice were anesthetized with 
a Ketamine 16%/Xylazine 4% solution and 1  ×  105  CFU of 
S. Typhimurium were administered by i.g gavage in 200  µl 
of PBS. For intraperitoneal infection (i.p), 1  ×  103  CFU of 
S. Typhimurium were injected in 100 µl of PBS in the peritoneal 
cavity. Survival, weight changes, and clinical symptoms were 
evaluated daily and classified according their clinical score 
(described in Table S1 in Supplementary Material).
Bacterial load Quantification
To evaluate bacterial loads in organs, mice were euthanized 
5 days post infection and spleen, liver, and ileum were recov-
ered and homogenized. The homogenized samples were serially 
diluted in PBS and plated on LB or McConkey agar plates. All 
colony forming units (CFUs) were quantified 24  h later and 
normalized based on organ weight.
cell Preparation and Flow cytometry
To evaluate the IL-10 production by different cells during 
S. Typhimurium infection, IL-10/GFP VertX mice were infected 
and euthanized at 5 days post infection. Spleens, mesenteric lymph 
nodes, livers, and small intestine were collected and single-cell 
suspensions were prepared by homogenization through a 70 µm 
cell strainer (BD Biosciences). Liver samples were cut in small 
pieces and treated with Krebs Ringer solution plus collagenase IV 
(20 UI Heparin, 20.1 mM HEPES, 2.5 mM de CaCl2, 2 mM de 
MgCl2, collagenase IV a 250 UI/ml) during 30 min at 37°C on a 
rotary shaker. Then, liver tissue suspension was incubated with 
buffer PEBD (PBS 1× pH7.2, 2 mM EDTA, 0.5% BSA, and 1,500 U/
ml DNase I) and, subsequently, processed for flow cytometry as 
previously described (28). For small intestine cells isolation, tissue 
was carefully removed of fecal and fat contents and detached of 
their mesentery and Peyer’s patches. Small intestine was opened 
longitudinally, washed thoroughly with 2% FCS HBSS, and cut 
into 0.5 cm segments. Sections were incubated twice in HBSS with 
2 mM EDTA for 20 min at 37°C on a rotary shaker. After each 
incubation step, supernatant was removed, along with epithelial 
cells and debris. The remaining tissue was incubated for 45 min 
in RPMI 1640 medium supplemented with 10% fetal calf serum 
(FBS), 2 mM glutamine, 1 mM non-essential aminoacids, 1 mM 
pyruvate, 1 mM HEPES, and 1 mg/ml collagenase VIII (Sigma-
Aldrich) at 37°C in agitation. Cell suspensions were finally 
passed through a 40-µm cell strainer and pelleted for labeling 
flow cytometry. Myeloid and lymphoid cells were characterized 
using specific surface markers: anti-Ly6C-BV605 (clone AL-21; 
BD PharMingen), anti-MHC-II-BV650 (clone M5/114.15.2; BD 
PharMingen), anti-CD24-BV421 (clone M1/69; BD PharMingen), 
anti-CD45-BV786 (clone 30-F11; BD PharMingen), anti-CD11c-
PE-Cy7 (clone N418; BD PharMingen), anti-CD103-PerCP-
Cy5-5 (clone M290, BD PharMingen), anti-CD11b-PE (clone 
M1/70; BD PharMingen), anti-Ly6G-AF700 (clone 1A8; BD 
PharMingen), anti-CD64-AF647 (clone X54-5/7.1; Biolegend), 
anti-CD8-BV605 (clone 53-6.7; BD PharMingen), anti-CD4-
BV650 (clone RM4-5; BD PharMingen), anti-CD3-PerCP-Cy5.5 
(clone 145-2C11; BD PharMingen), anti-CD19-PE (clone 6D5; BD 
PharMingen), anti-CD1d-BUV395 (clone 1B1; BD PharMingen). 
All FACS samples were first stained with LIVE/DEAD fixable 
Viability Stain 510 (BD PharMingen). The data were obtained 
in LSR Fortessa X-20 Flow cytometry (BD Biosciences) and 
analyzed in Flow Jo software V7.0. The gating strategy to identify 
myeloid and lymphoid GFP+ cells is shown in Figures S1 and S2 
in Supplementary Material, respectively.
intracellular staining for Detection of il-10 
and FoxP3 by Flow cytometry analyses
Six- to eight-week-old female C57BL/6 WT mice were anesthetized 
and challenged i.g. with either 1 × 105 CFU of S. Typhimurium 
or an equal volume of PBS (as uninfected control). At day 4 
post-infection, mice were euthanized and spleens, livers, and 
small intestine were collected and single-cell suspensions were 
prepared for flow cytometry, as described above. Cells suspen-
sions were stimulated with 10 µg/ml brefeldin A (Sigma-Aldrich) 
for 5  h prior to intracellular staining. Then, cells were stained 
with anti-CD45-BV786 (clone 30-F11; BD PharMingen), anti-
TCR-β-PE-Cy7 (clone H57-597; BD PharMingen), anti-CD4-
APC-H7 (clone RM4-5; BD PharMingen), anti-CD25-BV421 
(clone PC61; BD PharMingen). After staining, cells were fixed 
and permeabilized (Cytofix/Cytoperm kit; BD PharMingen) 
and, subsequently, stained intracellularly with anti-IL10 (clone 
JES5-16E3, BD PharMingen) and anti-Foxp3 (clone PE-CF594, 
BD PharMingen). All FACS samples were first stained with LIVE/
DEAD fixable Viability Stain 510 (BD PharMingen). The intracel-
lular stain was controlled by FMO and the analysis was performed 
using a LSR Fortessa X-20 Flow cytometry (BD Biosciences).
Multiplex cytokine assay
Blood was collected by cardiac puncture from IL-10−/− and WT 
mice infected i.g with 1 ×  105  CFU of S. Typhimurium. Total 
blood collected was mixed with 100 µl of heparin (125 UI/ml), 
maintained during 15 min at 37°C and centrifuged at 3,000 × g 
for 15 min. Serum was collected and stored at −80°C until used. 
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Levels of IL-1β, IL-6, IL-10, IFN-γ, IL-12p70, IL-23p19, and 
TNF-α were measured on a Luminex 200 (Merck Millipore), 
using a mouse magnetic luminex screening assay (R&D systems), 
according to manufacturer instructions.
Quantitative real-time Pcr
RNA from different organs of mice was purified using the SV Total 
RNA Isolation System (Promega), according to the manufacturer’s 
instructions. The same amount of messenger RNA (mRNA) for 
each sample was used to made the reverse transcription and 
PCRs, using TaqMan RNA-to-Ct 1-step kit (Applied Biosystems). 
Murine interleukin 10 (il-10; Assay ID: mm00439614_m1), trans-
forming growth factor-β (tgf-β; Assay ID: mm01178820_m1), 
forkhead box P3 (foxp3; Assay ID: mm00475162_m1), cytotoxic 
T-lymphocyte antigen 4 (ctla-4; Assay ID: mm01253995_m1), 
programmed cell death protein 1 (pd-1; Assay ID: mm01285676), 
and β-2-microglobulin (β2m: Assay ID: mm00437762) taqman 
probes (Applied Biosystems) were used to amplify RNA. 
Quantitative real-time RT-PCRs (qRT-PCRs) were carried out 
using a StepOne plus thermocycler (Applied Biosystems), with 
the following cycling conditions: 1 cycle of 48°C for 15 min and 
95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C 
for 1  min. For all tested samples, the expression of the target 
and the housekeeping gene (β2m) was calculated. The mRNA 
gene expression of every sample was normalized by dividing the 
mRNA value of the target gene with the appropriated β2m mRNA 
value. After the standardization, the abundance of each target 
mRNA was determined by the comparative method (2−ΔΔct) of 
StepOne software. All samples were analyzed at least by triplicate.
T and B cell isolation and stimulation
Mice were euthanized as described above and spleen from either 
IL-10−/− or WT mice were recovered. Total spleen cells were centri-
fuged at 300 × g for 10 min at 4°C and red blood cells were lysed using 
ACK buffer. Cells were washed, resuspended in RPMI 1640 medium 
supplemented with 10% FBS, and counted by trypan blue staining. 
B and T cells were purified by negative selection using the Pan B 
and T cells isolation kit, Miltenyi Biotec, respectively, according to 
manufacturer instructions. Isolated cells were counted by trypan 
blue staining and resuspended in RPMI medium to a concentration 
of 1 × 106 cells/ml. For cytokine production, 1 × 106 B or T cells 
were placed in eppendorf tubes and infected with S. Typhimurium 
(MOI:25) in antibiotic-free RPMI-1640 medium for 1  h at 37°C. 
Cells were washed and treated with gentamicin (100 µg/ml) for 1 
additional hour at 37°. Culture supernatants were collected after 24 h 
and stored at −80°C until used. In addition, purified B cells were 
stimulated either with LPS (1  µg/ml, S. Typhimurium; Sigma, St. 
Louis, MO, USA), or with anti-IgM antibody (10 µg/ml) for 24 h, 
or both. Similarly, purified T cells were stimulated over plates coated 
with anti-CD3/CD28 antibody (1 µg/ml) for 24 h. Levels of IL-10 
were measured in the supernatants of these cells using an ELISA Kit 
II (BD Biosciences).
cell adoptive Transfer experiments
For adoptive transfer studies, T and B cells were purified from the 
spleen of C57BL/6 WT mice using a magnetic cell-sorting column 
(MACS) according to the manufacturer’s instructions (Pan T and 
B cells isolation kit, Miltenyi Biotec). DCs and bone marrow-derived 
macrophages were differentiated and cultivated from bone marrow 
precursors of WT mice, as described before, and MACS enriched, 
respectively (Miltenyi Biotec). The purified cells were adoptively 
transferred (1  ×  106 cell/mouse) by intravenous injection into 
IL-10−/− mice or Rag.1−/− recipient mice (only T and B cells). After 
24 h, mice recipients were challenged via i.g. with 1 × 105 CFU of 
S. Typhimurium as described above. Animal survival and clinical 
parameters of infection were recorded daily. Bacterial load was 
evaluated in spleen and liver at the end of each experiment.
statistical analysis
Statistical analyses were performed using Prism v6 (GraphPad 
Software, San Diego, CA, USA). Unpaired Student’s t-test and 
Mann–Whitney U-test were used to assess whether the means of 
two normally distributed groups differed significantly. One-way 
ANOVA with Bonferroni’s multiple comparison post-test was 
used to compare multiple means. Two-way ANOVA analysis 
with repeated measures was also used in some experiments, 
with Sidak or Tukey post-test. Survival curves were compared 
using a Kaplan–Meier plot and log-rank test.
resUlTs
systemic Salmonella infection requires 
il-10 Production in Mice
To evaluate how IL-10 production in vivo influences the outcome 
of S. Typhimurium infection, intragastric and intraperitoneal 
infections were performed in C57BL/6 WT and IL-10−/− mice, 
and survival rates were evaluated daily for 30 days. As expected, 
we observed that in both infection models, IL-10−/− mice 
displayed significantly higher survival rates than WT mice 
(Figures 1A,B). Next, to demonstrate that IL-10−/− mice clear 
S. Typhimurium more efficiently than WT mice, bacterial loads 
were measured at 5 days post infection in ileum, liver, and the 
spleen. As shown in Figure 1C, IL-10−/− mice showed significantly 
less bacterial loads in the above-mentioned organs, as compared 
to WT mice. The reduced bacterial colonization and better 
survival of IL-10−/− mice correlates with higher levels of IFN-γ, 
IL-6, TNF-α, IL-12, and IL-23 in serum (Figure 1D). Notably, at 
the same time post infection, we observed that WT mice did not 
show an increase in these pro-inflammatory cytokines in serum, 
despite the high number of bacteria in the tissues. Moreover, the 
only cytokine that was significantly increased in the serum of the 
infected WT mice was IL-10. These results support the notion 
that IL-10 production during S. Typhimurium infection favors 
systemic infection caused by this bacterium in mice.
il-10-Producing cells reside in ileum, 
liver, and spleen after 5 Days of  
S. Typhimurium infection
To identify when and where IL-10 is produced during 
S. Typhimurium infection in WT mice, evaluation of the mRNA 
encoding IL-10 was performed in the most important target 
tissues of this bacterium, at 12, 24, 48, 72, 96, and 120  h post 
FigUre 1 | Absence of interleukin-10 (IL-10) production improves host survival and prevents systemic dissemination of S. Typhimurium. Wild-type (WT) C57BL/6 
and IL-10−/− mice were infected (a) orally and (B) intraperitoneally with S. Typhimurium (ST) and survival rate were followed for 30 days. (c) Bacterial burden in 
spleen, liver, and ileum and (D) cytokine production in serum were evaluated in orally infected WT and IL-10−/− mice at 5 days post infection. For survival assays, 
***P < 0.001 log-rank test. For colony forming units (CFUs) loads and cytokine quantification, a student’s t-test was performed between WT- and ST-infected mice; 
**P < 0.01; ***P < 0.001.
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oral infection with 1 × 105 CFUs. As shown in Figure 2 (upper 
panels), IL-10 encoding mRNA was significantly increased after 
120  h post infection in ileum (Figure  2A) <liver (Figure  2B) 
<spleen (Figure 2C). Other organs that are also S. Typhimurium 
targets, such as colon and mesenteric lymph nodes, did not show 
increased production of IL-10 encoding mRNA at any time 
evaluated (data not shown). To identify which CD45+ cells in 
ileum, liver, and spleen were the main IL-10 producers, trans-
genic IL-10/GFP VertX mice were infected with 1 × 105 CFUs of 
S. Typhimurium and IL-10-producing cells were evaluated at 
120 h post infection by flow cytometry. As shown in Figure 2, 
second and third panels, we observed a significantly increased 
number of CD45+IL-10-producing cells (GFP+ cells) in the ileum 
of the infected mice, as compared to uninfected mice. Importantly, 
our results show that the IL-10-producing cells in this tissue were 
mainly T cells. In the liver and spleen, although we did not detect 
a significantly increase of total CD45+IL-10-producing cells, we 
observed increased numbers of IL-10 producing monocytes, 
macrophages, and dendritic cells (DCs). Beyond the absolute cell 
number of IL-10-producing cells, we also quantified the inten-
sity of IL-10 GFP+ expression in these CD45+ leukocytes after 
S. Typhimurium infection. As shown in Figure 2 (fourth panel), 
increased GFP+ mean fluorescence intensity (MFI) was observed 
in ileum (DCs, macrophages, and CD4+ T cells) and spleen (DCs, 
monocytes, neutrophils, and CD8+ T cells). These results suggest 
that S. Typhimurium infection promotes both increased number 
of IL-10-producing cells and increased IL-10 production by 
resident cells in target tissues.
To evaluate whether S. Typhimurium infection induces 
the differentiation of Treg cells in these tissues, C57BL6 
mice we orally infected with 1  ×  105 CFUs and 96  h post-
infection were measured the amount of CD4+CD25+FoxP3+ and 
CD4+CD25+FoxP3− T cells in situ (as described in Figure S3 in 
Supplementary Material). As shown in Figure 3A (left panel), no 
difference in the amount of CD4+CD25+ T cells was observed in 
S. Typhimurium-infected mice, as compared to uninfected mice. 
However, in ileum and spleen of infected mice, we observed a 
significantly increase in the amount of CD4+CD25+FoxP3+ 
T  cells. On the other hand, in the liver, we observed a signifi-
cantly increase in the number of CD4+CD25+FoxP3− T cells. In 
addition, we observed that CD4+CD25+FoxP3+ T cells from the 
spleen also displayed an increase in MFI IL-10, suggesting that 
FigUre 2 | Interleukin-10 (IL-10) production significantly increases in target tissues after 120 h of S. Typhimurium infection. In the panels of the upper row, Il-10 
messenger RNA (mRNA) production was quantified by RT-PCR in ileum (a), liver (B), and spleen (c) of infected WT mice at different time post-infection. The panels 
of the second row show representative flow cytometry histograms obtained to identify the cell source of IL-10 production at 120 h post infection in ileum (a), liver 
(B), and spleen (c) of IL-10/GFP VertX that were orally infected by S. Typhimurium. In the third-row panels, a quantification of IL-10 producing total leukocytes, 
dendritic cells (DCs), macrophage, monocytes, neutrophils, CD4+ T cells, CD8+ T cells, CD19+CD1d− B cells, and CD19+CD1d+ B cells in ileum (a), liver (B), and 
spleen (c) were identified by flow cytometry. The quantification of IL-10/GFP+ cells was performed using count bright beads. The last row panels show the fold 
change of the medium fluorescence intensity of GFP/IL-10 in myeloid and lymphoid cell types during S. Typhimurium infection at 120 h post infection. For Il-10 
mRNA production, **P < 0.01; ***P < 0.001 (one-way analysis of variance test with a posteriori multiple comparison test).
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CD4+CD25+FoxP3+ T cells are an important source of IL-10 in 
the spleen (Figure 3B). We also determined the level of mRNA 
encoding proteins expressed in Tregs in ileum, spleen, and liver. 
As shown in Figure  3C, we observed increased expression of 
ctla-4 in ileum and liver but not in the spleen. Although the mean 
value was not statistically significant, we observed increased 
production of pd-1 in the liver of some infected mice. We did 
not observe changes in the expression of foxP3 or tgf-β in total 
FigUre 3 | S. Typhimurium infection induces the generation of regulatory T cells (Tregs cells). C57BL/6 mice were left uninfected or orally infected with 1 × 105 CFU 
of S. Typhimurium and after 96 h post infection of infection the ileum, liver, and spleen was recovered to detect the presence of Tregs. (a) Quantification of total 
CD4+CD25+; CD4+CD25+FoxP3+, and CD4+CD25+FoxP3− T cells. (B) Measurement of mean fluorescence intensity (MFI) of IL-10 secretion by flow cytometry in 
target tissues ex vivo. Gray bars = uninfected; black bars = infected. *P < 0.05, ***P < 0.001 (Student’s t-test). (c) Tregs cells markers expression in target tissues 
during S. Typhimurium infection. The quantification of messenger RNA (mRNA)-encoding Tregs cells markers were evaluated in target tissues infected by S. 
Typhimurium, using quantitative real-time RT-PCR at 5 days post infection with specific TAQMAN probes. β2-microglobulin gene was used as endogenous control. 
The results are shown as fold change of relative expression, compared with wild-type (WT) uninfected mice (ΔΔCT). Statistical analysis was performed using 
two-way ANOVA with Bonferroni post test (*P < 0.05; **P < 0.01; ***P < 0.0001).
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mRNA from infected tissues. In summary, our results allow us to 
conclude that S. Typhimurium induced the expression of IL-10 
in specific infected organs and that the main cellular sources 
of this cytokine are DCs, macrophages, monocytes, and T cells 
located in the ileum, liver and spleen. Our results also suggest that 
S. Typhimurium infection promotes CD4+CD25+FoxP3+ Treg 
cell response in ileum and spleen, which probably favors systemic 
disease after S. Typhimurium infection.
il-10 Production by T cells restores the 
susceptibility to S. Typhimurium systemic 
infection in il-10−/− Mice
To demonstrate that the production of IL-10 by certain subsets 
of immune cells is key to S. Typhimurium to cause systemic 
infection in mice, IL-10−/− mice were adoptively transferred with 
either T cells, B cells, DCs, or macrophages from WT mice that 
probably produce IL-10 in vivo after S. Typhimurium infection. 
The selection of these cells was based on previous studies show-
ing the relevance of IL-10 production by these cells in different 
experimental settings of S. Typhimurium infection (21, 22, 24, 
29–36), and according to the results showed in Figure 2, which 
suggest that these cells are contributing to IL-10 production 
in ileum, liver, and spleen at 120 h post infection. As controls, 
a group of uninfected mice and a group of infected mice that 
did not receive cells from WT mice were included. After 24  h 
of adoptive transfer, recipient mice were orally infected with 
1 × 105 CFUs of S. Typhimurium and survival, clinical score, and 
weight loss were evaluated for 14 days. As shown in Figure 4A, 
IL-10−/− mice that received T cells showed increased mortality as 
compared to IL-10−/− mice that received B cell, DCs, and mac-
rophages. Accordingly, IL-10−/− mice that received T cells showed 
FigUre 4 | Interleukin-10 (IL-10) production by T cells enhances the severity of the infection caused by S. Typhimurium in mice. Dendritic cells (DCs), BM 
macrophages, B cells, and T cells isolated from wild-type (WT) mice (1 × 106 cells) were adoptive transferred to IL-10−/− recipient mice. Twenty-four hours after cell 
transfer, recipient mice were orally infected with 1 × 105 CFU of S. Typhimurium. Then survival rate (a), clinical score (B), and weight loss (c) of DCs (ST + DCs), 
BMM (ST + BMMs), B cells (ST + B cells), and T cells (ST + T cells) recipient mice were followed over 14 days. As controls, uninfected/untransferred (Uninf + UT) 
and infected/untransferred (ST + UT) groups were added. After 5 days of infection, bacterial burden was evaluated in (D) spleen and (e) liver in eight randomly 
selected DCs, BMM, B cells, and T cell recipient mice. After 14 days of infection, serum of DCs, bone marrow-derived macrophages (BMM), B cells, and T cell 
recipient mice was obtained and cytokine production was evaluated by Luminex (F). B cells and T cells isolated from WT mice were adoptively transferred to 
Rag.1−/− mice. Twenty-four hours later, mice were orally infected with 1 × 105 CFU of S. Typhimurium, and survival (g), clinical score (h), and weight loss (i) were 
evaluated for 9 days. For CFUs and cytokine quantification in vivo *P < 0.05, ***P < 0.0001 by Kruskal–Wallis test compared with ST + UT mice (IL-10−/− mice 
infected untransferred). Statistical analysis of cytokine production is indicated by letters in the figure and was performed using two-way ANOVA with Bonferroni 
post-test. a: *P < 0.05; a: **P < 0.01; α,β: ***P < 0.0001; represents IL-10−/− mice infected and transferred with T (a, a, α) and B cells (b, β), respectively, compared 
with ST + UT mice. ɸ: *P < 0.05; IL-10−/− mice infected and transferred with BMMs compared with ST + UT mice. *P < 0.05 log-rank test was performed for 
survival curves; body weight changes and clinical score were analyzed using two-way ANOVA with Bonferroni post-test. IL-10−/− mice infected and transferred with 
T (a, a, α) and B cells (b, b, β) were compared with ST + UT mice, respectively. Statistical significance was indicated by letters. a,b: *P < 0.05; a,b: **P < 0.01; α,β: 
***P < 0.0001. Comparison between Uninf + UT mice and ST + UT mice was represented as c: *P < 0.05; c: ***P < 0.0001.
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a significant increase in clinical score and weight loss starting day 
7 post infection, as compared to uninfected mice and mice that 
received IL-10-producing DCs and macrophages (Figures 4B,C). 
Importantly, IL-10−/− mice that received B  cells also showed a 
significant increase in clinical score and weight loss; however, the 
survival rate at day 14 post infection was better than IL-10−/− mice 
that received T cells. Supporting these observations, IL-10−/− mice 
that received T cells showed the highest bacterial loads in spleen 
and liver, as compared to the other infected experimental groups. 
IL-10−/− mice recipient for B cells also showed increased bacterial 
loads only in spleen, as compared to infected mice that did not 
receive cells from WT mice (Figure 4D). To evaluate the level 
of IL-10 production and the amount of other pro-inflammatory 
cytokines in the recipient IL-10−/− mice, serum was obtained from 
all experimental groups after 14 days of infection. As observed in 
Figure 4F, IL-10−/− mice that received T cells showed the highest 
level of IL-10 in serum, followed by B-cell recipient IL-10−/− mice. 
Although IL-10−/− mice that received DCs and macrophages 
showed a slight increase in IL-10 in serum, the value detected 
was 100-time less than the levels of IL-10 found in T cells and 
B  cell recipient IL-10−/− mice. Importantly, IL-10−/− mice that 
received T  cells showed the highest level of pro-inflammatory 
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cytokines in serum at 14 days post-infection, as compared with 
infected IL-10−/− mice that did not receive IL-10-producing cells, 
which agrees with the high clinical score, weight loss, and mortal-
ity observed in these mice after infection. The above results are 
also in agreement with septicemia disease development in these 
animals.
Finally, to identify whether other IL-10-producing cells in 
the absence of T cells and B cells also influence the severity of 
S. Typhimurium infection, Rag.1−/− mice were orally infected 
with 1 ×  105 CFUs of S. Typhimurium, and survival, clinical 
score, and weight loss were evaluated during 9 days. As shown 
in Figures 4G–I, these mice (ST + UT) showed a mortality rate 
equivalent to WT C57BL/6 mice, suggesting that IL-10 produced 
by other cells than T and B cells indeed influence the outcome 
of S. Typhimurium infection. However, when these mice were 
adoptively transferred with T cells purified from WT mice, recipi-
ent mice showed an increased mortality rate (Figure 4G), clinical 
score (Figure 4H), and weight loss (Figure 4I), as compared to 
untransferred mice. Importantly, when Rag.1−/− were adoptively 
transferred with B  cells purified from WT mice, we did not 
observe an increased mortality, clinical score, or weight loss, as 
observed for IL-10−/− mice (Figures  4A–C). These results sug-
gest that IL-10 produced by B cells is likely not enough to fully 
recapitulate S. Typhimurium infection in the absence of T cells.
To control that IL-10-producing cells secrete this cytokine 
after direct contact with S. Typhimurium infection, we performed 
an in vitro assay in which DCs, B cells, and T cells were infected 
with S. Typhimurium for 2 h and, after 24 h post treatment, the 
production of IL-10 was tested by ELISA. As shown in Figure S4 
in Supplementary Material, the lowest level of IL-10 production 
after infection was observed in T cells. These results suggest that 
in vivo the direct infection of T cells by S. Typhimurium may not 
account for IL-10 production and, probably, the interaction of 
T cells with other S. Typhimurium-infected cells is required to 
induce the production of IL-10 by these cells in the infected host.
DiscUssiOn
In this study, we have demonstrated the role of IL-10 produc-
tion in the outcome of S. Typhimurium infection in mice, which 
supports the notion that the production of this cytokine by the 
host during infection is a key factor in the ability of the bacterium 
to cause systemic infection in susceptible hosts.
In bacterial infections, IL-10 is readily produced by cells from 
the innate immune system upon recognition of several pathogen-
associated molecular patterns (PAMPs) (37–41). However, 
there are multiple pro-inflammatory cytokines also produced 
by immune cells during an infection, which promote an acute 
inflammatory response to restrict bacterial dissemination to 
other tissues (13, 42, 43). In the case of S. Typhimurium, it has 
been described that bacterial recognition by cells from the innate 
immunity, such as neutrophils, macrophages, and DCs, promotes 
the secretion of pro-inflammatory cytokines (44–50). However, 
as shown in this study, at the beginning of the systemic phase of 
infection, pro-inflammatory cytokines cannot be detected in the 
serum of WT mice infected with S. Typhimurium, which are highly 
susceptible to infection caused by this bacterium. Importantly, 
we observed that among the cytokines tested in this study at 
5 days of infection, the only one that was elevated in the serum 
of infected mice was IL-10. On the other hand, the high levels 
of pro-inflammatory cytokines detected in the serum of infected 
IL-10−/− mice at similar time points post infection indicate that 
the absence of IL-10 allows the recognition of bacteria to generate 
an inflammatory immune response. Importantly, we observed a 
high level of serum IFN-γ in infected IL-10−/− mice at 5 days of 
infection, which is a cytokine important for the elimination of 
intracellular S. Typhimurium (51–54). These results suggest that 
in the absence of IL-10, PAMPs from S. Typhimurium can be 
readily recognized by the host and promote an inflammatory 
immune response, but in the presence of IL-10, this response 
seems to be totally turned off, despite the high bacterial loads 
found in the tissues of the infected mice.
In susceptible mice, it has been described that S. Typhimurium 
dampens the bactericidal capacity of phagocytic cells and reside 
intracellularly within a vacuole, aided by virulence proteins 
secreted to the host cells cytoplasm through the type three 
secretion system encoded in Salmonella Pathogenicity Island 2 
(SPI-2). This way, the phagolysosome activity of phagocytic cells 
is prevented and the intracellular bacteria cannot be cleared 
(16, 55–58). Furthermore, antigen presentation is impaired 
due to lack of antigen degradation, which in turn prevents the 
activation of the anti-Salmonella adaptive immune response 
(19, 59–61). Likely, the production of IL-10 enhances the ability 
of S. Typhimurium to survive intracellularly and prevent clearance. 
Previous reports have suggested that the presence of IL-10 
promotes the polarization of macrophages to the M2 phenotype 
(22), which suffer a metabolic change that increases the avail-
ability of intracellular glucose that, in turn, favor the intracellular 
replication of S. Typhimurium (62). In agreement with this idea, 
a previous study showed that, in macrophages, the production 
of the protein SpiC, which is encoded in SPI-2, induces the 
production of IL-10 in macrophages (29). Our results shown in 
Figure S4, Supplementary Material also support the notion that 
active replication of S. Typhimurium within innate immune cells 
increase the production of IL-10, because a higher amount of 
this cytokine is produced in DCs and BM macrophages infected 
with live bacteria, as compared to cells infected with heat-killed 
bacteria. The active production of IL-10 by infected phagocytic 
cells probably aids the intracellular survival of the bacteria and 
its dissemination from the intestine in early stages of the infec-
tion, favoring the colonization of other tissues, such as spleen 
and liver. Our results support this notion, since IL-10−/− mice 
have less bacteria in ileum, spleen, and liver at 5  days of oral 
infection. Moreover, some of the IL-10−/− mice evaluated in this 
study showed no bacteria in these tissues (Figure 1C).
In our experimental settings, the sole transfer of IL-10 pro-
ducing DCs and BM macrophages did not restore the ability 
of S. Typhimurium to cause a systemic and lethal infection in 
IL-10−/− mice. These results result suggests that the production of 
IL-10 that is required by S. Typhimurium to generate the systemic 
infection must be derived from adaptive immune cells. This 
statement is supported by our results showing that the transfer of 
IL-10-producing T cells recovered the ability of S. Typhimurium 
to cause a systemic infection in IL-10−/− mice. Importantly, the 
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sole presence of IL-10-producing T cells in infected IL-10−/− mice 
restores the levels of IL-10 in serum observed in infected WT mice. 
These observations suggest that the generation of a tolerogenic, 
antigen-specific immune response driven by T cells is required 
by S. Typhimurium to cause systemic infection in C57BL/6 mice. 
Or results are in agreement with a previous report showing the 
relevance of Treg cells to sustain replication of S. Typhimurium 
in a murine model of bacterial persistence (35). In this study, 
which was performed in mice resistant to S. Typhimurium infec-
tion (F1 129SvJ X C57BL/6), it was described that depletion of 
FoxP3+ T cells resulted in reduced bacterial loads in the spleen 
after 3 weeks of S. Typhimurium infection. Similar results were 
observed when mice were treated with an anti-CLTA-4 antibody.
It is important to mention that, in our study, we observed a 
peak of IL-10 production at 5 days of infection, which agrees 
with the idea that the main producer of IL-10 are adaptive 
immune cells, or even by other innate immune cells that respond 
to signals provided by these adaptive immune cells. Using the 
IL-10/GFP VertX mice, we observed a significant increase of 
IL-10-producing DCs, monocytes, macrophages, and T cells in 
the ileum of infected mice when the peak of IL-10 production 
was detected. We also observed that resident DCs, monocytes, 
macrophages, and T  cells in spleen probably increase their 
production of IL-10 upon S. Typhimurium infection. Moreover, 
we detected the presence of CD4+CD25+FoxP3+ T cells in ileum 
and spleen, which support the notion that Treg cells are being 
generated in S. Typhimurium-infected mice. It is important to 
mention that the detection of IL-10+ T cells in spleen observed 
in Figure  2, using IL-10/GFP VertX mice did not match the 
results found in Figure  3, was intracellular staining of IL-10 
and FoxP3 was performed for T cells from WT-infected mice. 
It is important to consider that both models represent differ-
ent ways to measure IL-10 production, and Figure  3 shows 
the results in a specific subset of T cells. Since the amount of 
Tregs in the tissues was quite low, it is expected that differences 
in sensitivity among both models account for the differences 
observed for IL-10-producing T  cells in spleen. Furthermore, 
in the liver of the infected mice, we observed an increase of 
CD4+CD25+FoxP3− T and increased expression of ctla-4 and 
pd-1, but we did not observe an increase in the expression of 
foxP3 in any tissue. Again, this assay should be read carefully, 
because total mRNA from each tissue was evaluated and the 
amount of CD4+CD25+FoxP3+ T  cells increased in the ileum 
and spleen of infected mice is very low. Nevertheless, our result 
suggests that at the beginning of the systemic phase, Tregs cells 
are probably located in the intestine and liver, which agrees 
with previous reports showing that these tissues would be the 
preferred sites for Treg cells homing after infection with this and 
other pathogens (39, 63–69).
Another important finding in our study is the role of IL-10-
producing B cell to restore the susceptibility to S. Typhimurium 
in IL-10−/− mice. As shown in Figure 4, the transfer of IL-10-
producing B  cells increase the clinical score and enhance 
weight loss of infected IL-10−/− mice, as compared to mice 
that receive IL-10-producing DCs and BM macrophages. The 
levels of mortality of these mice showed a slight increase, 
the bacterial loads were increased in the spleen, and these 
mice also showed increased levels of inflammatory cytokines 
in serum. However, these parameters were not equivalent 
in magnitude to those found in IL-10−/− mice that received 
IL-10-producing T  cells. This observation suggests that the 
production of IL-10 by B cells after S. Typhimurium infection 
reaches levels in the host that can support replication and dis-
semination of the bacterium. Indeed, it has been described that 
B cells can produce IL-10 after recognition of S. Typhimurium 
LPS through TLR-4, which is relevant to the early stages of 
the infection (21). However, in our experimental settings, we 
observed that the production of IL-10 by these cells cannot 
fully reverse the resistant of IL-10−/− mice to the infection. 
Moreover, transfer of B cells did not increase the susceptibil-
ity of Rag.1−/− mice to S. Typhimurium, while the transfer of 
T cells increased the susceptibility of these mice to the infec-
tion (Figures  4G,I). These results suggest that B  cells may 
provide additional signals to T  cells during S. Typhimurium 
infection that promotes the generation of Treg cells. In agree-
ment with this idea, previous in  vitro studies have shown 
that S. Typhimurium can infect and persist in B cells, plasma 
cells, and bone marrow precursors of B  cells (70) and that 
infected cells express PD-L1 and PD-L2, which can promote 
the differentiation of T cells to Treg cells (71, 72). Therefore, the 
interplay between infected B cells and T cells can be key to the 
development of a tolerogenic immune response triggered by 
S. Typhimurium infection.
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